SELECTA BIOSCIENCES INC Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Description of Securities (Filed With SEC on March 7, 2024)
- Description of Securities (Filed With SEC on March 2, 2023)
- Description of Securities (Filed With SEC on March 10, 2022)
- Promotion Letter dated May 11, 2021, between Selecta Biosciences, Inc. and Ann K. Donohue (Filed With SEC on August 12, 2021)
- Description of Securities (Filed With SEC on March 12, 2021)
- Letter agreement, dated August 31, 2020, among Selecta Biosciences, Inc., Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on September 3, 2020)
- Open Market Sale Agreement, dated as of August 6, 2020, by and between Selecta Biosciences, Inc. and Jefferies LLC (Filed With SEC on August 6, 2020)
- Description of Securities (Filed With SEC on March 12, 2020)
- OPEN MARKET SALE AGREEMENTSM (Filed With SEC on August 11, 2017)
- [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with... (Filed With SEC on August 11, 2017)
- SPARK THERAPEUTICS, INC.3737 MARKET STREET, SUITE 1300"PHILADELPHIA, PA 19104P215.220.9300SPARKTX.COM (Filed With SEC on December 14, 2016)
- THIRD AMENDMENT (Filed With SEC on December 14, 2016)
- Summary of Oral Agreement between Dr. Omid Farokhzad and Selecta Biosciences, Inc. (Filed With SEC on June 8, 2016)
